Ehealth ((EHTH)) has held its Q1 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Ehealth’s latest earnings call painted a cautiously optimistic picture, as management acknowledged sharp revenue and volume declines while underscoring meaningful gains in unit economics, margins and cash generation. Executives framed 2026 as a deliberate “bridge year” in which the company sacrifices growth to solidify profitability, highlighting improved Medicare economics, tighter cost controls and a credible multi‑year path back to growth.
Revenue Ahead of Expectations Despite Pullback
Ehealth reported first quarter 2026 revenue of $88.0 million, which exceeded internal expectations even as it fell materially year over year. Management stressed that the company is prioritizing quality over volume in 2026, accepting lower top‑line in order to build a more profitable and durable book of Medicare business.
Medicare Unit Economics Show Clear Improvement
The company’s Medicare LTV‑to‑CAC ratio improved to 1.4x from 1.2x, a 17% gain that signals better returns on marketing spend. Medicare Advantage lifetime value rose 3% while total acquisition cost per MA‑equivalent approved member declined 10%, pointing to healthier unit economics despite softer volumes.
Marketing Spend Falls as Channel Mix Improves
Variable marketing cost per MA‑equivalent approved member dropped 28%, reflecting a deliberate cutback in low‑quality demand. Non‑GAAP marketing and advertising expense fell 38%, with variable marketing down 44%, as Ehealth shifted more budget toward branded, higher‑conversion channels it believes will drive better long‑term value.
Margin Expansion in Medicare Segment
Medicare segment gross profit slipped 8% year over year to $33 million, but gross margin expanded sharply from 34% to 41%. Management attributed the improvement to better LTV‑to‑CAC dynamics and higher‑quality enrollments, framing this as proof that its disciplined growth strategy is paying off.
Adjusted EBITDA Positive, Operating Cash Flow Strong
Adjusted EBITDA came in at $9.0 million, surpassing internal plans even though it was down versus last year. Operating cash flow was a solid $35.8 million, and leadership pointed to these metrics as evidence that the 2026 cash‑flow‑focused playbook is gaining traction early in the year.
Fixed Cost Cuts and Expense Discipline
Ehealth has implemented headcount reductions and vendor consolidations that are expected to lower fixed operating costs by about $30 million in 2026, roughly a 20% cut versus 2025. Non‑GAAP total operating expenses, excluding stock‑based compensation and restructuring, fell 21% to $82.3 million, underscoring tighter cost discipline across the organization.
New Products and Operating Model Initiatives
The company launched its lifetime advisory model and rolled out final expense insurance in April, expanding its product suite. New agent‑facing tools, including a member dashboard, system‑driven recommendations and dynamic scripts, are designed to boost retention and support cross‑selling across the Medicare customer base.
Lifetime Values Rising Across Product Lines
Ehealth reported broad‑based gains in lifetime values, with Medicare Advantage up 3%, Medicare Supplement up 19% and PDP up 78%. Management argued these improvements validate its focus on higher‑quality enrollments and enhance the economics of cross‑selling ancillary products over time.
Balance Sheet Strength and Growing Receivables
The company ended the quarter with $110.8 million in cash, cash equivalents and short‑term marketable securities, reinforcing its liquidity profile. Commission receivable value grew 12% year over year to just over $1.0 billion, reflecting the embedded future revenue stream in its existing Medicare book.
Three‑Year Profitability and Growth Targets
Management’s updated three‑year outlook calls for a return to revenue growth, with mid‑single‑digit gains in 2027 and mid‑teens growth in 2028. The plan also targets adjusted EBITDA margin expansion to roughly 20% by 2028 and breakeven or better free cash flow in 2027, signaling a shift from stabilization to profitable growth.
Sharp Year‑Over‑Year Revenue Decline
Total revenue fell 22% year over year to $88.0 million, highlighting the near‑term pressure from the strategic pullback in marketing. Medicare segment revenue mirrored this trend, also down 22% to $81.3 million, as the company deliberately traded volume for improved economics and channel quality.
Enrollment Volume and Submissions Under Pressure
Medicare submissions declined 24% compared with the prior year, reflecting reduced acquisition volume tied to lower marketing spend. Management maintained that this is a conscious choice to emphasize profitable growth and high‑quality channels rather than chasing headline enrollment numbers in 2026.
GAAP Results Swing to a Net Loss
Ehealth posted a GAAP net loss of $4.7 million in the first quarter, versus GAAP net income of $2.0 million a year earlier. The reversal was largely driven by restructuring charges associated with headcount reductions, which management views as necessary to reset the cost base.
Adjusted EBITDA and Cash Flow Down Versus Last Year
Adjusted EBITDA decreased to $9.0 million from $12.5 million and the adjusted EBITDA margin slipped to 10% from 11%, reflecting lower revenue and volume. Operating cash flow of $35.8 million was down from $77.1 million, with management citing timing factors, severance costs and lower commission collections as the main drivers.
Weakness in Employer and Individual Segment
The Employer and Individual segment saw revenue decline 29% to $6.7 million, signaling ongoing softness outside the core Medicare franchise. Segment gross profit dropped to $3.7 million from $6.0 million, underscoring that the turnaround remains heavily dependent on Medicare performance.
Lower Tail Revenue in the Quarter
Recognized net adjustment, or tail, revenue totaled $8.0 million, down from $10.5 million in the prior year. Management updated its 2026 net adjustment revenue guidance to a range of $8 million to $20 million, reflecting a more conservative stance on this variable income stream.
Higher Customer Care and Enrollment Unit Costs
Customer care and enrollment cost per MA‑equivalent approved member rose 9% year over year, partially offsetting the gains from lower marketing CAC. The increase stems from lower application volume and the decision to retain agent capacity to support the lifetime advisory model, which management believes will pay off in future retention and cross‑sell.
Forward‑Looking Guidance and Strategic Roadmap
Ehealth reaffirmed its 2026 guidance ranges for revenue, GAAP net income, adjusted EBITDA and operating cash flow, while updating tail revenue expectations to $8 million to $20 million. The company continues to position 2026 as a bridge year aimed at breakeven operating cash flow and paving the way for breakeven free cash flow in 2027, supported by fixed cost cuts, ancillary sales, future ICHRA revenue and a modest re‑acceleration in Medicare marketing.
Management closed the call by reinforcing a balanced narrative of near‑term pain in exchange for long‑term gain, as revenue and enrollment decline but margins, unit economics and cash discipline improve. For investors, the key takeaway is a high‑conviction plan that leans on a stronger Medicare franchise, a lighter cost structure and a multi‑year trajectory toward profitable growth, even as headline results remain pressured in the short term.